ClinConnect ClinConnect Logo
Search / Trial NCT06292377

Better Understanding of Fatigue After STroke

Launched by BRUGMANN UNIVERSITY HOSPITAL · Feb 27, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Better Understanding of Fatigue After Stroke," is exploring the issue of extreme tiredness, known as post-stroke fatigue (PSF), that many people experience after having a stroke. PSF can greatly affect a person's daily life and their ability to recover. Researchers want to understand how problems with the autonomic nervous system (which controls involuntary bodily functions) and heart issues that can occur after a stroke might contribute to this fatigue. They will look at heart rate patterns and other factors to see if they can find connections between these issues and the fatigue patients feel.

To participate in this study, individuals must be at least 18 years old, have had their first ischemic stroke (a type of stroke caused by a blockage in blood flow) within the last 72 hours, and be admitted to a specific stroke unit in Belgium. Participants will undergo assessments to measure their fatigue, mood, and cognitive abilities, and will also have an MRI of their brain. The goal is to gather more information that could help improve understanding and treatment of fatigue after a stroke, ultimately leading to better care for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18
  • First-ever (suspicion of) ischemic stroke based on clinical examination and/or brain imaging
  • Onset \< 72h at time of inclusion
  • Admitted at the stroke unit of CHU Brugmann and UZ Brussel
  • Ability to participate in assessment of fatigue, cognitive, mood and sleep disturbances
  • Ability to undergo MRI of the brain
  • Exclusion Criteria:
  • Unable to speak French, Dutch or English
  • Pre-existing stroke or other structural brain lesion
  • Life expectancy \< 1 year
  • Severe language impairment or dementia impeding assessment of fatigue, cognitive, mood and sleep disturbances
  • Pregnancy or wish to become pregnant

About Brugmann University Hospital

Brugmann University Hospital is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative clinical research. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, focusing on a wide range of therapeutic areas. With a team of highly skilled researchers and clinicians, Brugmann University Hospital promotes collaboration across disciplines to enhance patient care and contribute to the development of new treatment modalities. Its state-of-the-art facilities and dedication to ethical research standards ensure the highest quality of clinical trial management and patient safety.

Locations

Brussels, , Belgium

Brussel, , Belgium

Patients applied

0 patients applied

Trial Officials

Anissa Ourtani, MD

Principal Investigator

CHU Brugmann

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported